an Istitution Experience on Parosteal OsTeosarcoma

Completed

• Conditions: Parosteal Osteosarcoma

• Registration Number: NCT03768076
• Lead Sponsor: Istituto Ortopedico Rizzoli

Brief Summary

single institution cases series review of histological and clinical data

Detailed Description

Investigators will review all the cases with a diagnosis of primary parosteal osteosarcoma treated at the Rizzoli Institute from 1900 up to 31 July 2018, retrospectively.

Study Timeline

• Study First Submitted: 2018-11-22
• Study Start: 2018-11-30
• Study First Submitted QC: 2018-12-05
• Study First Posted: 2018-12-07
• Primary Completion: 2019-02-28
• Study Completion: 2019-02-28
• Status Verified: 2021-07
• Last Update Submitted: 2021-07-30
• Last Update Posted: 2021-08-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 220

Inclusion Criteria

• Male and female patients treated at Rizzoli Institute from 01 Jan 1900 to 31 Jul 2018
• Diagnosis of parosteal osteosarcoma
• Written informed consent prior to any study-specific analysis and/or data collection

Exclusion Criteria

• Patients with histological diagnosis different from parosteal osteosarcoma

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
retrospective analysis of cases of Parosteal osteosarcoma	at baseline (Day0)	Investigators will exam the presence of progression (dedifferentiation) areas and the relationship of these factors to individual outcome.

Trial Locations

Locations (1)

Istituto ortopedico Rizzoli; 🇮🇹 Bologna, Italy